Paper35205
Pharmacokinetics of single and multiple doses of clobazam in humans.
Rupp W and 8 others. Br J Clin Pharmacol, 1979. Cited by 88 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pharmacokinetics of single and multiple doses of clobazam in humans. Papers, record 35205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35205
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Anxiety Agents | Major topic |
| Benzodiazepines | |
| Chemical Phenomena | |
| Chemistry, Physical | |
| Dealkylation | |
| Half-Life | |
| Humans | |
| Kinetics | |
| Nomifensine |
Source PubMed
References3
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,242,342 | [Analytical methods I]. | Arzneimittelforschung | 1975 | https://conductscience.org/library/papers/1242342 | PubMed |
| 2 | 334,216 | Kinetic interaction of nomifensine with a 1, 5-benzodiazepine (clobazam). | Br J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/334216 | PubMed |
| 3 | 35,199 | Clobazam: chemical aspects of the 1,4 and 1,5-benzodiazepines. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/35199 | PubMed |
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,295,251 | Physiologically Based Pharmacokinetic Modeling of Clobazam and Stiripentol Co-Therapy in Dravet Syndrome. | J Pers Med | 2025 | https://conductscience.org/library/papers/41295251 | PubMed |
| 40,733,022 | Population Pharmacokinetics and Model-Informed Precision Dosing of Clobazam Based on the Developmental and Genetic Characteristics of Children with Epilepsy. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40733022 | PubMed |
| 37,701,253 | Elevations in Norclobazam Concentrations and Altered Mental Status in CYP2C19 Poor Metabolizer Phenotype: A Case Report. | Neurohospitalist | 2023 | https://conductscience.org/library/papers/37701253 | PubMed |
| 30,791,225 | A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects. | Clin Pharmacol Drug Dev | 2019 | https://conductscience.org/library/papers/30791225 | PubMed |
| 30,285,275 | A Comprehensive Overview of the Clinical Pharmacokinetics of Clobazam. | J Clin Pharmacol | 2019 | https://conductscience.org/library/papers/30285275 | PubMed |
| 30,187,002 | Systematic review of clobazam use in patients with status epilepticus. | Epilepsia Open | 2018 | https://conductscience.org/library/papers/30187002 | PubMed |
| 29,517,622 | PharmGKB summary: clobazam pathway, pharmacokinetics. | Pharmacogenet Genomics | 2018 | https://conductscience.org/library/papers/29517622 | PubMed |
| 28,815,428 | The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs. | J Med Toxicol | 2017 | https://conductscience.org/library/papers/28815428 | PubMed |
| 27,769,254 | Effects of clobazam for treatment of refractory status epilepticus. | BMC Neurol | 2016 | https://conductscience.org/library/papers/27769254 | PubMed |
| 26,089,675 | Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox-Gastaut syndrome. | Ther Clin Risk Manag | 2015 | https://conductscience.org/library/papers/26089675 | PubMed |
| 25,917,225 | Clobazam: A Safe, Efficacious, and Newly Rediscovered Therapeutic for Epilepsy. | CNS Neurosci Ther | 2015 | https://conductscience.org/library/papers/25917225 | PubMed |
| 25,511,520 | Clinical considerations in transitioning patients with epilepsy from clonazepam to clobazam: a case series. | J Med Case Rep | 2014 | https://conductscience.org/library/papers/25511520 | PubMed |
| 25,503,589 | Pharmacokinetics of clobazam and N-desmethylclobazam in children with dravet syndrome receiving concomitant stiripentol and valproic Acid. | Clin Pharmacokinet | 2015 | https://conductscience.org/library/papers/25503589 | PubMed |
| 25,052,507 | A physiologically based pharmacokinetic model for clobazam and stiripentol in adults and children. | Pharm Res | 2015 | https://conductscience.org/library/papers/25052507 | PubMed |
| 23,318,278 | Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies. | Ther Drug Monit | 2013 | https://conductscience.org/library/papers/23318278 | PubMed |
| 23,034,582 | Clobazam : in patients with Lennox-Gastaut syndrome. | CNS Drugs | 2012 | https://conductscience.org/library/papers/23034582 | PubMed |
| 22,145,708 | GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam. | CNS Drugs | 2012 | https://conductscience.org/library/papers/22145708 | PubMed |
| 17,199,029 | Clobazam. | Neurotherapeutics | 2007 | https://conductscience.org/library/papers/17199029 | PubMed |
| 11,735,655 | Treating epilepsy in the elderly: safety considerations. | Drug Saf | 2001 | https://conductscience.org/library/papers/11735655 | PubMed |
| 6,661,360 | No effect of food intake on clobazam absorption. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6661360 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35205
GET https://conductscience.org/api/papers/v1/35205/cited_by?page=2